Pulse Biosciences, Inc. Cash and Cash Equivalents
Pulse Biosciences, Inc. (PLSE) had Cash and Cash Equivalents of $101.62 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-06
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $101.62M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $68.32M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $80.73M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $95.21M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $101.62M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $68.32M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $80.73M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $95.21M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $106.35M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $119.28M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $118.04M 10-K · filed 2026-02-19 | |
| 2024-09-30 | $79.03M 10-Q · filed 2024-10-30 | |
| 2024-06-30 | $26.20M 10-Q · filed 2024-08-19 | |
| 2024-03-31 | $34.88M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $44.37M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $50.39M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $58.75M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $54.10M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $61.14M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $69.16M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $14.80M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $12.68M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $44.37M 10-Q · filed 2024-10-30 | $28.61M 10-K · filed 2022-03-31 |
| 2021-09-30 | $41.99M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $47.43M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $59.88M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $12.46M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $7.07M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $37.77M 10-Q · filed 2021-08-09 | |
| 2020-03-31 | $7.86M 10-Q · filed 2021-05-10 | |
| 2019-12-31 | $6.90M 10-Q · filed 2021-11-15 | |
| 2019-09-30 | $9.57M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $10.78M 10-Q · filed 2020-08-10 | |
| 2019-03-31 | $8.54M 10-Q · filed 2020-05-11 | |
| 2018-12-31 | $51.10M 10-K · filed 2021-03-12 | |
| 2018-09-30 | $6.33M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $6.79M 10-Q · filed 2019-08-08 | |
| 2018-03-31 | $10.67M 10-Q · filed 2019-05-03 | |
| 2017-12-31 | $3.39M 10-K · filed 2021-03-12 | |
| 2017-09-30 | $32.42M 10-Q · filed 2018-11-01 | |
| 2017-06-30 | $1.99M 10-Q · filed 2018-07-31 | |
| 2017-03-31 | $2.75M 10-Q · filed 2018-05-08 | |
| 2016-12-31 | $2.09M 10-K · filed 2020-03-16 | |
| 2016-09-30 | $4.63M 10-Q · filed 2017-11-08 | |
| 2016-06-30 | $20.21M 10-Q · filed 2017-08-10 | |
| 2016-03-31 | $2.10M 10-Q · filed 2017-05-10 | |
| 2015-12-31 | $3.61M 10-K · filed 2019-03-14 | |
| 2015-09-30 | $4.95M 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $5.94M 10-Q · filed 2016-08-10 | |
| 2015-03-31 | $6.55M 10-Q · filed 2016-06-27 | |
| 2014-12-31 | $7.01M 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |